Clinical Trial Update: BF2.649 in Patients With OSA and Treated by CPAP But Still Complaining of EDS [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for BF2.649 in obstructive sleep apnea patients on CPAP who still report excessive daytime sleepiness; the study status is complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Excessive Daytime Sleepiness
• Obstructive Sleep Apnea

Drugs mentioned

• BF2.649 (BF2.649)

Snippet

Sponsor: Bioprojet | Conditions: Obstructive Sleep Apnea, Excessive Daytime Sleepiness | Phase 3 | Status: COMPLETED